Juniper pharmaceuticals inc (JNP)
CashFlow / TTM
Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Class of Stock
Class of Stock
Series C Preferred Stock [Member]
Operating activities:
Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Net income (loss)

-

153

-

-

-

6,153

5,951

-4,639

-4,519

-3,157

-1,496

250

3,626

4,522

4,656

3,010

984

3,651

4,741

8,248

6,918

6,204

9,917

0

0

0

-

-

-

-

Reconciliation of net loss to net cash used in operating activities:
Depreciation and amortization

2,389

2,359

2,253

2,132

2,008

1,894

1,899

1,844

1,847

1,877

1,911

2,030

2,073

2,067

1,992

2,007

1,654

1,259

919

577

664

745

642

487

272

125

166

0

0

0

Change in fair value of common stock warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-379

-696

-1,123

-898

-794

0

0

0

-

-

-

-

-

-

-

-

Stock-based compensation expense

1,693

1,694

1,469

1,613

1,571

1,424

1,201

1,160

1,321

1,336

1,750

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Write-off of inventories

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

970

867

817

422

58

0

0

0

Change in value of redeemable warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Change in fair value of stock warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

Recognition of deferred income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Provision for sales returns

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-222

205

217

358

0

0

0

Stock-based compensation expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

368

453

454

668

802

798

933

814

0

0

0

Deferred tax liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

542

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Loss on disposal of fixed assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-37

-38

-38

0

-8

-6

-6

-4

-3

0

0

0

Changes in operating assets and liabilities:
Accounts receivable

3,865

3,728

-2,178

1,132

856

-2,924

-192

-1,878

463

3,477

2,499

3,211

-182

-1,834

-1,705

-1,898

-558

505

2,347

-58

1,053

1,710

-1,776

2,245

-4,353

158

902

0

0

0

Due from related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-900

-901

-842

-816

-1,295

0

0

0

-

-

-

-

-

-

-

-

Inventories

1,067

624

704

1,057

1,275

2,484

1,998

1,856

159

-120

424

129

232

927

619

862

963

163

-46

-1,612

-1,446

-2,059

-39

1,230

2,277

2,653

1,396

0

0

0

Prepaid expenses and other current assets

1,122

752

1,849

768

-215

-518

-64

-1,721

-849

-417

-259

1,001

642

467

331

-1,476

-464

-729

-1,439

1,327

-11

13

616

-56

304

193

275

0

0

0

Other non-current assets

-

-

-

-

-

-

-18

54

76

76

89

0

0

0

-

-

-

-62

50

86

115

-309

-425

-425

-425

-1

-19

0

0

0

Accounts payable

3,903

2,663

183

-354

-1,093

-1,705

1,585

1,379

985

1,345

-925

2,295

-228

-625

91

-1,452

229

716

315

-1,504

-1,204

-2,310

-2,456

-464

-885

295

-2,095

0

0

0

Accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

40

-896

-9

260

-354

-510

42

-245

-311

-218

-989

-1,578

-1,917

-1,838

0

0

0

Accrued expenses and other

0

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-598

-165

455

1,645

1,036

490

1,033

-92

916

1,212

-1,038

-970

-1,728

-2,017

-1,334

1,492

1,548

1,340

1,493

-69

-39

-43

-13

175

210

90

125

0

0

0

Net cash used in operating activities

-

1,164

-

-

-

10,677

11,186

716

-331

-344

-891

3,062

6,023

5,869

6,929

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

801

2,839

1,320

-1,339

0

0

0

Investing activities:
Purchases of property and equipment

4,528

3,195

2,840

3,712

3,766

3,364

3,564

2,749

2,385

2,260

1,708

1,721

1,337

1,417

2,048

1,817

1,647

1,308

522

247

52

81

986

1,662

1,726

2,219

1,307

0

0

0

Proceeds from Sale of Property, Plant, and Equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Net cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-1,912

-16,828

-14,280

-13,309

0

0

0

Financing activities:
Additions to short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

Net cash used in investing activities

-

-3,195

-

-

-

-3,364

-3,564

-2,749

-2,385

-2,260

-1,708

-1,721

-1,337

-1,417

-2,048

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of common stock / exercise of options

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

33

18

28

23

11

0

0

0

-

-

-

-

2,641

0

0

0

Proceeds from equipment loans

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Principal payments on debt

533

1,461

1,402

1,320

1,247

248

226

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments to satisfy employee taxes due on vesting of restricted awards

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

653

0

0

0

Principal payments on notes payable

-

-

-

-

-

-

-

-

-

-

-

240

242

246

245

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Payments for the purchase of treasury stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

8,509

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Dividends paid

-

-

14

21

21

28

28

28

28

28

28

28

28

28

28

28

28

28

28

0

0

0

-

-

30

30

30

0

0

0

Net cash provided by financing activities

-

813

-

-

-

1,225

-254

-285

-293

-204

-206

-169

-171

-253

-8,749

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-57

-30

442

3,139

0

0

0

Effect of exchange rate changes on cash and cash equivalents

-

144

-

-

-

-249

-275

-158

-146

-23

-56

-122

-140

-141

-85

0

0

0

-

-

-

-58

46

26

-25

8

-7

0

0

0

Net (decrease) increase in cash and cash equivalents

-

-1,074

-

-

-

8,289

7,093

-2,476

-3,155

-2,831

-2,861

1,050

4,375

4,058

-3,953

-2,420

-19,666

-1,528

7,511

8,631

23,704

6,219

3,090

-1,141

-14,043

-12,508

-11,516

0

0

0

Supplemental cash flow information
Cash paid for interest

-

138

-

-

-

86

85

92

94

98

101

103

107

111

120

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for income taxes

-

-

-

-

-

-

-

-

-

-

2

2

2

2

3

3

3

3

3

0

0

0

-

72

147

193

220

0

0

0

Supplemental noncash information
Purchases of equipment through accounts payable and accrued expenses

463

203

320

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Reclassification of redeemable warrant liability to capital in excess of par value

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0